According to a recent market study published by Growth Market Reports titled, “Global Flow Cytometry System Market by Technology, Products and Services, Applications, End-users and Regions: Size, Share, Trends, and Opportunity Analysis, 2017-2027”, the market was valued at USD 4,298.1 Million in 2019 and is expected to expand at a CAGR of 10.0% during the forecast period.

The global flow cytometry system market is anticipated to grow, owing to rise in the prevalence of the cancer, which has led to the rise in the adoption of the flow cytometry systems. Flow cytometry systems are also used for the analysis and estimation of the cytotoxicity in the cells. Flow cytometry systems, are also used for the determination of the progress of the disease, which are some of the major factors, which constitutes for the demand for flow cytometry systems. Adoption, of advanced methods, which includes, rapid detection, higher resolution, cell analyzers, and software systems, ensures, the efficacy in the analysis and estimation of the cell toxicity, and structure of the cells. These are some of the advantages of using flow cytometry systems.

The global flow cytometry system market is fragmented based on technology, products and services, applications, end-users. On the basis of technology, the flow cytometry system market is bifurcated into cell-based flow cytometry and bead-based flow cytometry. Based on applications, the market is segmented into research applications, immunology, cell sorting, apoptosis, cell cycle analysis, cell viability, cell counting, and others. The cell sorting segment is estimated to account for a significant share of the market. In terms of clinical applications, the market is segregated into cancer diagnostic, hematology, immunodeficiency diseases, organ transplantations, and other clinical applications. Rising demand for the diagnosis of cancer is anticipated to boost the cancer diagnostic segment during the forecast period.

Request a free sample copy:

Based on regions, the global flow cytometry system market is classified as North America, Europe, Latin America, and Middle East & Africa. North America is bifurcated into countries such as the US and Canada. The Europe region is categorized as the Germany, France, Italy, U.K., Spain, Russia, Rest of Europe. Asia Pacific is split into countries, China, Japan, South Korea, India, Australia, South East Asia (SEA), Rest of Asia Pacific (APAC). Latin America is categorized as Brazil, Mexico, Rest of Latin America (LATAM), while the MEA is divided into Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa (MEA).

In year 2020, the flow cytometry system market is expected to witness the growth due to COVID-19 pandemic. The outbreak has led to the rise in the adoption of flow cytometry techniques, for the analysis of COVID-19 during this pandemic. This is impacting the demand for flow cytometry systems. The rising prevalence of diseases has led to the rise in the demand for the flow cytometry systems. The increasing occurrence of cancer are also some of the factors, which has contributed for the demand for the flow cytometry systems. This is anticipated to create lucrative opportunity for flow cytometry systems manufacturers during this pandemic situation.

As per Growth Market Reports industry analyst Akshata Ahire, “The Global Flow Cytometry System Market is anticipated to expand at significant pace during the forecast period, from 2020 to 2027. The market is driven by the rising adoption of flow cytometry systems by the hospitals and clinics and rising prevalence of diseases are some of the factors boosting the market.”

Key Takeaways from the Study

  • North America accounts for a significant share of the market, followed by Asia Pacific. The market in India is projected to expand at significant CAGR during the forecast period.
  • In terms of value, the bead-based flow cytometry segment is projected to increase at a substantial CAGR during the forecast timeline.

Report Scope

Report Metric


Market Value in 2019

USD 4,298.1 Million

Market Growth Rate (from 2021 to 2027)


Historical Data

2017 & 2018

Base Year


Forecast Period

2020 - 2027

Units Considered

Value (USD Million)

Market Segments

Technology, Products and Services, Applications, and End-users

Regional Scope

North America, Europe, Latin America, Asia Pacific, and Middle East & Africa (MEA)

Country Scope

 US, Canada, Brazil, Mexico, Rest of Latin America, India, China, Japan, South Korea, Australia, South East Asia, Rest of Asia Pacific, the UK, France, Germany, Italy, Spain, Russia, Rest of Europe, Saudi Arabia, South Africa, the UAE, and Rest of MEA.

Key Companies Profiled

Agilent Technologies Inc., Apogee Flow Systems, Danaher Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioMeriux SA, Cytek Biosciences, Cytonome/ST LLC, Enzo Life Sciences, Inc., GE Healthcare, Luminex Corporation, QIAGEN N.V., Merck KGaA, Miltenyi Biotec GmbH, Sartorius AG, Sony Biotechnology, Inc., Stratedigm, Inc., Sysmex Partec GmbH,
Takara Bio Inc., Thermo Fisher Scientific, Inc., and Harvard Bioscience Inc.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements

Target Audience

  • Supply-side: Flow Cytometry Systems manufacturers, raw material suppliers, and distributors
  • Demand Side: Hospitals, healthcare technicians, diagnostic centers, academic and research institutes
  • Regulatory Side: concerned government authorities, government agencies, and other regulatory bodies
  • Associations and Industry Bodies: The US Food and Drugs Administration (FDA), Code of Federal Regulations, American Association of Pharmaceutical Scientists, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, American Cancer Society